Human SNP ID | rs10518159 |
---|---|
Human chromosome | chr4 |
Human SNP position | 76842845 |
Pig chromosome | chr13 |
Pig SNP position | 196252453 |
PubMed ID | 21844884 |
---|---|
Journal | Pharmacogenomics J |
Link | www.ncbi.nlm.nih.gov/pubmed/21844884 |
Study | Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations |
Disease/Trait | Response to platinum-based chemotherapy (cisplatin) |
Initial sample | 176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines |
Replication sample | NA |
Region | 4q21.1 |
Chromosome id | chr4 |
Chromosome position | 76842845 |
Reported gene | intergenic |
Mapped gene | LOC105377289 - SOWAHB |
Upstream gene id | 105377289 |
Downstream gene id | 345079 |
SNP gene ids | |
Upstream gene distance | 40321 |
Downstream gene distance | 52084 |
SNP risk allele | rs10518159-? |
SNPs | rs10518159 |
Merged | 0 |
SNP id current | 10518159 |
Context | intergenic_variant |
Intergenic | 1 |
Allele frequency | |
P value | 0.000001 |
Pvalue mlog | 6 |
P value text | |
Or beta | |
%95 Ci | |
Platform | NR [~ 3000000] (imputed) |
CNV | N |
Mapped trait | response to cisplatin |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0072718 |
Study accession | GCST001201 |